Palbociclib + Letrozole Versus Epirubicin + Cyclophosphamide and Sequential Docetaxel as Neoadjuvant Chemotherapy
Clinical trial NCT04137640 · UNKNOWN
Trial details
- NCT number
- NCT04137640
- Sponsor
- Shengjing Hospital
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-19
- Primary completion
- 2025-11-30
- Enrollment
- 152
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.